Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma.

O'Day SJ, Eggermont AM, Chiarion-Sileni V, Kefford R, Grob JJ, Mortier L, Robert C, Schachter J, Testori A, Mackiewicz J, Friedlander P, Garbe C, Ugurel S, Collichio F, Guo W, Lufkin J, Bahcall S, Vukovic V, Hauschild A.

J Clin Oncol. 2013 Mar 20;31(9):1211-8. doi: 10.1200/JCO.2012.44.5585. Epub 2013 Feb 11.

2.
3.

Medical therapy of advanced malignant epithelial tumours of the ovary.

Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A.

Forum (Genova). 2000 Oct-Dec;10(4):323-32. Review.

PMID:
11535983
4.

Nab-paclitaxel in patients with metastatic melanoma.

Leon-Ferre RA, Markovic SN.

Expert Rev Anticancer Ther. 2015;15(12):1371-7. doi: 10.1586/14737140.2015.1110024. Epub 2015 Nov 4. Review.

PMID:
26536477
5.

Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study.

El Sayed SM, Mohamed WG, Seddik MA, Ahmed AS, Mahmoud AG, Amer WH, Helmy Nabo MM, Hamed AR, Ahmed NS, Abd-Allah AA.

Chin J Cancer. 2014 Jul;33(7):356-64. doi: 10.5732/cjc.013.10111. Epub 2014 Mar 14. Review.

6.

Botanicals for the prevention and treatment of cutaneous melanoma.

Syed DN, Mukhtar H.

Pigment Cell Melanoma Res. 2011 Aug;24(4):688-702. doi: 10.1111/j.1755-148X.2011.00851.x. Epub 2011 Apr 12. Review.

7.

Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate.

Chipman SD, Oldham FB, Pezzoni G, Singer JW.

Int J Nanomedicine. 2006;1(4):375-83. Review.

Items per page

Supplemental Content

Write to the Help Desk